Google searches about toothpaste are surging this weekend, and “toothpaste lawsuit” is one of the questions readers type, because of a recall of products distributed nationwide, several of them made for kids. The FDA’s Enforcement Report for event 100140 lists a voluntary, firm-initiated recall by ORL Labs LLC of Scottsdale, Arizona, covering six ORL Organic Oral Care products: three toothpastes, including a Bubblegum Kids toothpaste, and three mouthwashes, two of them labeled for kids. According to that report, the recall began on October 12, 2026, the FDA classified it as a Class II recall on November 6, 2026, distribution was nationwide, and the reason given is cross-contamination: the firm was notified by the FDA of sampling results that found progesterone, estradiol or DHEA in product samples. The report lists 51,762 units across the six products, states that the firm notified recipients by letter, notes that no press release was issued for this recall, and shows the recall as ongoing. It does not state the amount of any hormone found or how the contamination occurred.
The discussion that follows is general in scope: it describes checks useful in comparable situations and makes no findings about ORL Labs’ situation. It answers the two questions buyers are actually typing: can you sue over a recalled toothpaste or mouthwash, and can you simply get your money back? The short answer is that a recall is an FDA process, not a court judgment; a refund is usually a retail or warranty question; and a lawsuit for money depends on facts about your own tube or bottle that three federal appeals courts have spelled out in recent recall cases.
I. Can you sue over a recalled toothpaste or mouthwash, and what do courts require?
A. A recall is not a lawsuit: what the FDA’s Class II classification does and does not decide
Start with what the recall itself means in law. Under 21 C.F.R. § 7.3, a recall is a firm’s removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers. The same federal regulation sets out three classes. A Class II recall is “a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” Class I is reserved for situations with a reasonable probability of serious adverse health consequences or death, and Class III for products not likely to cause adverse health consequences. The classification is a statement about the degree of health hazard the FDA assigns to the recall. It is not a finding that any particular buyer was harmed, and it is not a court ruling on anyone’s liability.
The recall in the FDA report is described as firm-initiated. Under 21 C.F.R. § 7.46, a firm may remove or correct a distributed product on its own initiative, including when the FDA has informed it that the agency considers the product to violate the law but has not specifically requested a recall; the firm then provides the FDA with information such as the reason for the removal, the risk evaluation, the quantities in distribution and its proposed recall strategy, and the FDA assigns the classification. The FDA’s rules on recall communications in 21 C.F.R. § 7.49 say a recalling firm is responsible for promptly notifying its direct accounts, and that a recall communication should identify the product, size and lot numbers and give specific instructions on what to do with the recalled products. Public notice runs through the agency: under 21 C.F.R. § 7.50, “The Food and Drug Administration will promptly make available to the public in the weekly FDA Enforcement Report a descriptive listing of each new recall according to its classification.” That is why the most reliable place to check whether your product is covered is the Enforcement Report itself, not a news summary or a social media post.
The FDA’s own consumer explanation, Recalls Background and Definitions, repeats the three classes and notes that recalls may be conducted on a firm’s own initiative, by FDA request, or by FDA order under statutory authority. This guidance page describes the process; it does not create rights for consumers. The FDA report for this event lists the products under the product type “Drugs,” which is why the drug provisions of the federal statute are the relevant ones here. Under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 351 defines when a drug is “adulterated,” for example when the methods, facilities or controls used to make it do not conform to current good manufacturing practice, or when a substance has been mixed or packed with it so as to reduce its quality or strength. 21 U.S.C. § 331(a) then prohibits introducing an adulterated or misbranded drug into interstate commerce. Whether any recalled lot meets one of those definitions is a question for the agency and, if it ever came to that, for a court; the recall report does not decide it, and this article does not either.
The most practical point for a buyer is that the federal drug law is not something you can sue under directly. 21 U.S.C. § 337(a) provides that “all such proceedings for the enforcement, or to restrain violations, of this chapter shall be by and in the name of the United States,” subject to a limited exception for certain food-labeling actions by states. That is why the consumer cases discussed below were not brought “under the FDCA.” They were brought under state law: state consumer-fraud statutes, implied warranty of merchantability, unjust enrichment, negligent misrepresentation and, in some cases, product liability. Many of these cases end up in federal court anyway. Under the Class Action Fairness Act, 28 U.S.C. § 1332(d)(2) gives federal district courts original jurisdiction over a class action in which the matter in controversy exceeds $5,000,000 and any member of the plaintiff class is a citizen of a State different from any defendant. Once a case is in federal court, the buyer must also satisfy Article III standing, the constitutional requirement of a concrete and particularized injury. That requirement is where each of the three recall cases below was decided.
B. What three federal appeals courts decided about buyers of recalled or contaminated products
The Seventh Circuit drew the line most sharply in In re Recalled Abbott Infant Formula Products Liability Litigation, No. 23-2525 (7th Cir. Apr. 2, 2024). According to the opinion, Abbott Laboratories announced a voluntary recall of certain infant formula made at its Sturgis, Michigan plant after an FDA investigation, and offered a full refund to consumers who had that formula. A putative class of buyers seeking only economic losses sued, arguing that they would not have paid for formula at risk of contamination. The Seventh Circuit affirmed the dismissal for lack of standing. It held that the buyers did not allege that any of the products they purchased were contaminated, nor facts suggesting that contamination was widespread enough to plausibly affect any given unit, and it stated plainly: “The potential risk of contamination is not enough to confer standing.” The court also reasoned that, once the buyers learned of the risk, they were told not to use the formula and a refund was offered. For a buyer of recalled toothpaste or mouthwash, the lesson of the Abbott case is that a recall notice alone does not prove that your own tube or bottle was affected, so a claim for your money back needs facts tying your unit to the problem. The opinion also notes that personal-injury claims in the same litigation were a separate category and remained pending in the district court, which shows that the standing ruling concerned only economic-loss buyers.
The Third Circuit reached a more nuanced result in Huertas v. Bayer US LLC, No. 23-2178 (3d Cir. Nov. 7, 2024). As the court describes the case, Bayer recalled Lotrimin and Tinactin antifungal spray products in October 2021 after discovering benzene in products dating back to 2018, and nine buyers who alleged no physical injury sought compensation for economic loss. The Third Circuit accepted their benefit-of-the-bargain theory: a contaminated product that consumers were told to stop using is worth less than the properly manufactured product they thought they were buying. But it insisted that each buyer show that his or her own product was affected, holding that “Plaintiffs need only plausibly allege that they purchased contaminated products” while agreeing with the district court that the mere fact of a recall was not enough. The court reversed the dismissal for the four buyers who had identified lot numbers covered by the recall and remanded, and it upheld the dismissal of the buyers who had not alleged a recalled lot number. In practice, Huertas turns the lot number printed on your tube or bottle into the most important piece of evidence you own. The court also stressed that buyers need not prove that every recalled unit was contaminated, and it sent the case back for the district court to apply that plausibility standard, including to additional material the buyers had raised on appeal.
The Ninth Circuit added a third piece in Bowen v. Energizer Holdings, Inc., No. 23-55116 (9th Cir. Oct. 1, 2024). The buyer there alleged that the Banana Boat sunscreen she bought contained benzene, contrary to representations that the products were safe, and she had one bottle she had kept tested by a laboratory, which reported 0.29 parts per million. The district court dismissed for lack of standing, relying on an FDA guideline it read as permitting 2 parts per million of benzene in sunscreen. The Ninth Circuit reversed. It held that when the standing question is intertwined with the merits of a false-advertising claim, a court facing a factual challenge must treat it like a summary-judgment motion and cannot resolve genuinely disputed facts against the buyer; it held that a buyer who paid more than she otherwise would have, or bought a product she otherwise would not have bought, because of an actionable misrepresentation or omission has an injury in fact; and it observed: “The FDA guidance does not establish as a matter of law that sunscreen with benzene levels under 2 ppm is safe for human use.” For a buyer whose case would be heard by a federal court in Arizona, California or another Ninth Circuit state, Bowen means that a claim built on a label or safety representation and on testing of the buyer’s own product can get past an early standing challenge even when the defendant points to an FDA guideline. Under 28 U.S.C. § 41, the Ninth Circuit covers Alaska, Arizona, California, Idaho, Montana, Nevada, Oregon, Washington, Guam and Hawaii; the Third Circuit covers Delaware, New Jersey, Pennsylvania and the Virgin Islands; and the Seventh Circuit covers Illinois, Indiana and Wisconsin.
Read together, the three decisions give a consistent working rule rather than a contradiction. None of them treats a recall as automatic proof that every buyer was injured. Abbott rejects a claim built only on the risk that some units were contaminated. Huertas accepts that a contaminated, unusable product is worth less, but keeps only the buyers who could tie their purchase to a recalled lot. Bowen allows a misrepresentation-based overpayment claim to proceed where the buyer had testing of her own product and the facts about safety were genuinely disputed. Each ruling binds federal courts only within its own circuit, each concerned a different product, and each was decided at the pleading or early standing stage, not after a trial. They do not tell you that a hormone finding in a toothpaste sample makes any particular tube worthless; they tell you what a court will want to see before it lets a buyer’s claim go forward.
Two further limits matter for anyone reading class-action advertisements in the coming weeks. First, these were economic-loss cases. A buyer who claims a physical injury is in a different position: none of the three courts was deciding an injury claim, and such a claim turns on proof that the product caused the harm. Second, standing under Article III is a federal-court requirement. The Ninth Circuit itself noted in Bowen that whether a plaintiff satisfies the economic-injury element of a state false-advertising claim is a distinct inquiry from whether the plaintiff satisfies Article III. A case filed in state court, under state law, may therefore turn on different questions, and nothing in this article predicts how any court would rule on a claim arising from the current recall.
II. What should a buyer do now: refund, evidence, health concerns and notice?
A. Getting your money back: retailer refunds, warranty law and why a refund offer matters
For most households the realistic remedy is a refund, and the first step is to confirm whether your product is actually covered. The Enforcement Report lists six products and their UPC codes: Bubblegum Kids natural toothpaste (UPC 850006245505), Cinnamint toothpaste (850006245512), Fresh Mint natural toothpaste (850006245499), Bubblegum Kids Mouthwash (850006245475), Cinnamint Kids Mouthwash (850006245468) and Fresh mint mouthwash (850006245451). For each product the report lists specific lot codes and expiration dates between September 2026 and August 2028. Compare the UPC and the lot code printed on your own tube or bottle with the report, not with a re-posted list, because only the listed lots are part of the recall described in the report.
The FDA’s consumer guidance on understanding drug recalls explains that Class II drug recalls are generally conducted at the retail level, that companies may advise consumers to return recalled medications to their place of purchase, and that “Most retailers have established return and refund policies for recalled products.” The same guidance says consumers can generally continue using a product subject to a Class II recall unless the recalling company provides other instructions, and recommends talking to a doctor or pharmacist with questions. A toothpaste or mouthwash is easy to replace, and many parents will reasonably prefer to set a recalled children’s product aside while they sort out a refund; setting it aside is different from throwing it away, for the evidence reasons explained below. Ask the store or online seller where you bought it for its recall refund procedure, and keep the receipt, order confirmation or card statement that shows the purchase. If you have read our explanation of your rights after a Class II drug recall involving metal particles, the same logic applies here: the recall notice and the retailer’s policy usually decide the practical refund, while the legal claims sit in state law.
If a seller refuses a refund, state warranty law is the usual legal backstop, and it is state-specific. Arizona, where the recalling firm is located according to the FDA report, illustrates how it works, but a buyer’s own state law may govern a particular purchase. Under Arizona’s version of the Uniform Commercial Code, A.R.S. § 47-2314 implies a warranty of merchantability in a sale by a merchant who deals in goods of that kind, and merchantable goods must, among other things, be “fit for the ordinary purposes for which such goods are used” and conform to the promises or affirmations of fact made on the container or label. Arizona’s A.R.S. § 47-2715 lists the incidental and consequential damages a buyer may claim after a seller’s breach, and expressly includes “Injury to person or property proximately resulting from any breach of warranty.” There is also a procedural trap. A.R.S. § 47-2607(C)(1) provides that where goods have been accepted, “The buyer must within a reasonable time after he discovers or should have discovered any breach notify the seller of breach or be barred from any remedy.” In Arizona, a short written message to the seller identifying the product, the lot code and the recall is a sensible way to protect that remedy.
Arizona’s Consumer Fraud Act, A.R.S. § 44-1522(A), declares unlawful the use of deception, misrepresentation or the concealment or omission of a material fact, with intent that others rely on the omission, in connection with the sale or advertisement of merchandise. That statute targets deceptive conduct; a recall, by itself, does not establish any deception, and a consumer-fraud claim would need facts about what was represented and what was known when the product was sold. This is the same distinction the Ninth Circuit drew in Bowen, where the buyer’s overpayment theory rested on alleged misrepresentations or actionable omissions about safety.
The Abbott decision adds a point that buyers rarely consider: a prompt refund offer can weigh against a later class claim for economic loss. In that case the Seventh Circuit reasoned that once buyers learned of the potential contamination, they were told not to use the product and a refund was offered, so, in the court’s words, “there was not a time when plaintiffs were at a risk of harm.” That reasoning concerned buyers who did not claim their own units were contaminated and who did not claim any injury. It does not mean that asking for a refund waives a personal-injury claim, and the opinion says nothing of the kind. It does mean that, for a purely economic loss, the store refund may be worth more to you than a share of a hypothetical class settlement, and that a buyer who wants to preserve a stronger claim should keep the evidence that would tie the purchase to a recalled lot.
B. If you or your child used the product: health questions, evidence to keep and claims for injury
If anyone in the household has used a recalled product and you are worried about hormone exposure, the first call is medical, not legal. The FDA’s consumer guidance recommends talking to a doctor or pharmacist with questions about a recalled product. If you believe a product caused a problem, the FDA’s MedWatch program accepts reports from health professionals, patients and consumers, and the FDA’s description of the program lists over-the-counter medicines and cosmetics among the products it covers. A report to MedWatch is not a legal claim; it informs the agency’s safety monitoring and creates a dated record of what you observed.
The three appeals decisions point to the same evidence list. Keep the tube or bottle rather than discarding it, store it away from children, and photograph the front label, the UPC, the lot code and the expiration date. Keep proof of purchase. Write down when you bought the product, who used it, how often and for how long, and when you stopped. If a doctor examines a family member, keep the visit records and any test results. In Huertas, the buyers who could name a recalled lot number stayed in the case and the others did not; in Bowen, the buyer’s own laboratory test of a bottle she had kept was part of what carried her past the standing challenge; in Abbott, the absence of any allegation that the buyers’ own units were contaminated ended the economic-loss case. Testing a product yourself is not required to ask for a refund, and private laboratory testing has costs and limits, but the decisions show why the physical product and its lot code are worth preserving before anyone decides whether a claim is worth pursuing.
A claim for physical injury is a different kind of case from the refund and overpayment claims discussed above. In the Abbott litigation, the Seventh Circuit noted that the personal-injury cases were a separate category of claims and remained pending in the district court while the economic-loss buyers’ appeal was decided; in Huertas, the court emphasized that the buyers did not allege physical injuries and that the economic injury it recognized was not for costs associated with adverse health consequences. Under Arizona’s warranty statute, injury to person proximately resulting from a breach of warranty is listed among the consequential damages a buyer may claim, which means the claimant must connect the injury to the product. A Class II classification is not evidence that any particular person was injured; by its regulatory definition it describes a situation in which adverse health consequences may be temporary or medically reversible, or serious consequences are remote. Anyone considering an injury claim therefore needs medical evidence first, and should be wary of any solicitation that promises compensation without asking for it.
Finally, keep an eye on where information comes from. As of November 22, 2026, a search of the CourtListener RECAP docket feed returned no federal case naming ORL Labs filed since September 1, 2026; that feed reflects only documents uploaded to it, so the search is a snapshot, not proof that no case exists anywhere. Search results for “toothpaste lawsuit” are dominated by pages about earlier, unrelated toothpaste cases and settlements involving other brands, with their own classes and claim procedures; none of those applies to this recall merely because the product is also a toothpaste. If a class action is filed over this recall, the complaint will contain allegations, not findings, and the court will decide whether any buyer has standing and a valid claim. Our earlier guide to what shoppers can demand after a federal food recall follows the same sequence for food products: check the official listing, keep the product and the receipt, ask for the refund, and separate any health problem from the money question.
Conclusion
A toothpaste recall raises two different legal questions, and buyers do best when they keep them apart. Getting your money back is usually a matter of the recall listing, the retailer’s recall policy and, if needed, state warranty law, which in Arizona, for example, requires the buyer to notify the seller of a breach within a reasonable time. Suing for money is harder than the volume of “toothpaste lawsuit” searches suggests. Federal drug law is enforced in the name of the United States, so consumer claims rest on state law, and in federal court three appeals courts have required buyers to show that their own product was affected: a recall notice or a general risk is not enough, a recalled lot number can be, and testing of the buyer’s own unit can matter when the facts about safety are disputed. Health concerns come first and belong with a doctor; a claim for physical injury depends on medical proof that the product caused it. The practical steps are the same whatever happens next: compare the UPC and lot code with the FDA Enforcement Report, keep the product, the label photographs and the proof of purchase, ask the seller for the recall refund in writing, and treat any future complaint as a set of allegations until a court rules on it.